Empowering Philanthropy: A Strategic Guide to Supporting Cancer Research and Patient Advocacy on November 17, 2026 Posted by
Beyond the Pour: Massive Study Uncovers Complex Links Between Alcohol Types and Longevity on November 17, 2026 Posted by
The Trojan Horse of Hematology: Marrow Therapeutics Emerges with $173 Million to Revolutionize Bone Marrow Medicine on November 17, 2026 Posted by
Beyond the CPAP: Understanding the Role of GLP-1s in Managing Obstructive Sleep Apnea on November 17, 2026 Posted by
Roche’s New Breast Cancer Drug Wilserdly Receives FDA Approval: A New Era for Oral SERDs on November 17, 2026 Posted by
The Pillars of Healing: Understanding the Significance of National Recovery Month 2026 on November 17, 2026 Posted by
Empowering Philanthropy: A Strategic Guide to Supporting Cancer Research and Patient Advocacy on November 17, 2026 Posted by
Beyond the Pour: Massive Study Uncovers Complex Links Between Alcohol Types and Longevity on November 17, 2026 Posted by
The Trojan Horse of Hematology: Marrow Therapeutics Emerges with $173 Million to Revolutionize Bone Marrow Medicine on November 17, 2026 Posted by
Beyond the CPAP: Understanding the Role of GLP-1s in Managing Obstructive Sleep Apnea on November 17, 2026 Posted by
Posted in Sleep Health FDA Grants Orphan Drug Designation to Tris Pharma’s TRN-257, a Potential Breakthrough for Idiopathic Hypersomnia on July 16, 2026
Posted in Respiratory Health Genetic Breakthrough: New Polygenic Risk Score Transforms Idiopathic Pulmonary Fibrosis Prognosis on July 14, 2026
Posted in Sleep Health The Hidden Burden: Cognitive Impairment in Narcolepsy and Idiopathic Hypersomnia on July 14, 2026
Posted in Sleep Health The Hidden Burden: New Study Reveals Cognitive Impairment as a Primary Driver of Disability in Narcolepsy and Idiopathic Hypersomnia on July 5, 2026
Posted in Sleep Health Beyond the Wakefulness Gap: How Cognitive Impairment Redefines Life with Narcolepsy and Idiopathic Hypersomnia on June 23, 2026
Posted in Sleep Health Advancing Sleep Medicine: Alkermes Secures Key Orphan Drug Designations for Alixorexton in Narcolepsy and Idiopathic Hypersomnia on June 17, 2026
Posted in Sleep Health Breakthrough in Sleep Medicine: Alkermes’ LUMRYZ Shows Promise for Idiopathic Hypersomnia in Phase 3 Trial on June 2, 2026 rifanmuazin
Posted in Sleep Health Breakthrough in Sleep Medicine: Alkermes’ LUMRYZ Shows Promise for Idiopathic Hypersomnia in Phase 3 Study on May 22, 2026 rifanmuazin
Posted in Medical Innovations Regenerative Breakthrough: Oorja Bio Launches with $30M to Tackle Idiopathic Pulmonary Fibrosis on May 21, 2026 rifanmuazin
Posted in Respiratory Health Breakthrough in Idiopathic Pulmonary Fibrosis: TETON Trials Signal New Era for Nebulized Treprostinil on May 19, 2026 rifanmuazin